Neuroproteomics and systems biology‐based discovery of protein biomarkers for traumatic brain injury and clinical validation
暂无分享,去创建一个
Firas H Kobeissy | Zhiqun Zhang | R. Hayes | Kevin K. W. Wang | S. Larner | G. Robinson | M. Oli | Zhiqun Zhang | Monika W Oli | Ronald L Hayes | Kevin K W Wang | Shankar Sadasivan | Shankar Sadasivan | Stephen F Larner | Gillian Robinson | Firas H. Kobeissy | Firas H Kobeissy
[1] Jing Zhang,et al. Identification of Proteins Involved in Microglial Endocytosis of α-Synuclein , 2007 .
[2] B. Romner,et al. Biochemical serum markers for brain damage: a short review with emphasis on clinical utility in mild head injury. , 2003, Restorative neurology and neuroscience.
[3] B. Rowlands,et al. Neuron-specific enolase as an aid to outcome prediction in head injury. , 1996, British journal of neurosurgery.
[4] F. Tortella,et al. Comparing calpain- and caspase-3-mediated degradation patterns in traumatic brain injury by differential proteome analysis. , 2006, The Biochemical journal.
[5] R. L. Hayes,et al. Maitotoxin Induces Calpain But Not Caspase-3 Activation and Necrotic Cell Death in Primary Septo-Hippocampal Cultures , 1999, Neurochemical Research.
[6] C. Price,et al. The early fall in levels of S-100 beta in traumatic brain injury. , 2000, Clinical chemistry and laboratory medicine.
[7] A. Ebert,et al. Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomography. , 2000, Journal of neurotrauma.
[8] C. Oliveira,et al. Mitochondrial Dysfunction and Reactive Oxygen Species in Excitotoxicity and Apoptosis: Implications for the Pathogenesis of Neurodegenerative Diseases , 2003, Neurochemical Research.
[9] D. Jo,et al. Proapoptotic Effects of Tau Cleavage Product Generated by Caspase-3 , 2001, Neurobiology of Disease.
[10] A. Brawanski,et al. S-100B Protein Serum Levels After Controlled Cortical Impact Injury in the Rat , 2000, Acta Neurochirurgica.
[11] Cooper Eh. Neuron-Specific Enolase , 1994, The International journal of biological markers.
[12] J. Trojanowski,et al. Protein accumulation in traumatic brain injury , 2007, NeuroMolecular Medicine.
[13] O. Alonso,et al. Monoubiquitination and Cellular Distribution of XIAP in Neurons after Traumatic Brain Injury , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[14] B. Romner,et al. Renal elimination of protein S-100beta in pigs with acute encephalopathy. , 2001, Scandinavian journal of clinical and laboratory investigation.
[15] D. Daly,et al. ELISA microarray technology as a high-throughput system for cancer biomarker validation , 2006, Expert review of proteomics.
[16] G. Clifton,et al. Immunohistochemical study of calpain-mediated breakdown products to alpha-spectrin following controlled cortical impact injury in the rat. , 1997, Journal of neurotrauma.
[17] S. Sealfon,et al. Structure of the GnRH receptor-stimulated signaling network: insights from genomics , 2003, Frontiers in Neuroendocrinology.
[18] J. Bazarian,et al. Serum S-100B and cleaved-tau are poor predictors of long-term outcome after mild traumatic brain injury , 2006, Brain injury.
[19] D. Menon,et al. Discordant temporal patterns of S100 β and cleaved tau protein elevation after head injury: a pilot study , 2002, British journal of neurosurgery.
[20] Eckart D Gundelfinger,et al. Proteomics Analysis of Rat Brain Postsynaptic Density , 2004, Journal of Biological Chemistry.
[21] S. Grant,et al. Proteomics in Neuroscience: From Protein to Network , 2001, The Journal of Neuroscience.
[22] R. Gilbertsen,et al. Non-erythroid alpha-spectrin breakdown by calpain and interleukin 1 beta-converting-enzyme-like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis. , 1996, The Biochemical journal.
[23] Laszlo Prokai,et al. Proteomic analysis of the synaptic plasma membrane fraction isolated from rat forebrain. , 2003, Brain research. Molecular brain research.
[24] B. Pike,et al. Temporal relationships between de novo protein synthesis, calpain and caspase 3‐like protease activation, and DNA fragmentation during apoptosis in septo‐hippocampal cultures , 1998, Journal of neuroscience research.
[25] MartinWiesmann,et al. S-100 Protein and Neuron-Specific Enolase Concentrations in Blood as Indicators of Infarction Volume and Prognosis in Acute Ischemic Stroke , 1997 .
[26] T. Dóczi,et al. Spectrin breakdown products in the cerebrospinal fluid in severe head injury – preliminary observations , 2005, Acta Neurochirurgica.
[27] Trey Ideker,et al. Building with a scaffold: emerging strategies for high- to low-level cellular modeling. , 2003, Trends in biotechnology.
[28] V. Seifert,et al. Protein S-100B as a serum marker of brain damage in severe head injury: preliminary results , 2000, Neurosurgical Review.
[29] R. Hayes,et al. A novel marker for traumatic brain injury: CSF alphaII-spectrin breakdown product levels. , 2004, Journal of neurotrauma.
[30] P. Svenningsson,et al. Peptidomics-based discovery of novel neuropeptides. , 2003, Journal of proteome research.
[31] J. Hoheisel,et al. Antibody microarrays: promises and problems. , 2002, BioTechniques.
[32] J. Rafols,et al. Disruption of MAP-2 immunostaining in rat hippocampus after traumatic brain injury. , 1998, Journal of neurotrauma.
[33] V. Seifert,et al. Correlation of Computed Tomography Findings and Serum Brain Damage Markers Following Severe Head Injury , 1998, Acta Neurochirurgica.
[34] A. Usui,et al. S-100ao protein in blood and urine during open-heart surgery. , 1989, Clinical chemistry.
[35] J. Olney,et al. Sensitivity of the developing rat brain to hypobaric/ischemic damage parallels sensitivity to N-methyl-aspartate neurotoxicity , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[36] Sophia Ananiadou,et al. Text mining and its potential applications in systems biology. , 2006, Trends in biotechnology.
[37] G. Opiteck,et al. Biomarker discovery in biological fluids. , 2005, Methods.
[38] G. Tomei,et al. Traumatic Intracerebellar Hemorrhage: Clinicoradiological Analysis of 81 Patients , 2002, Neurosurgery.
[39] M. Sjögren,et al. The Use of Proteomics in Biomarker Discovery in Neurodegenerative Diseases , 2005, Disease markers.
[40] B. Pike,et al. Concurrent Assessment of Calpain and Caspase-3 Activation after Oxygen–Glucose Deprivation in Primary Septo-Hippocampal Cultures , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[41] B. Romner,et al. Traumatic brain damage: serum S-100 protein measurements related to neuroradiological findings. , 2000, Journal of neurotrauma.
[42] E. Cooper. Neuron-specific enolase. , 1994, The International journal of biological markers.
[43] B. Pike,et al. Temporal Profile and Cell Subtype Distribution of Activated Caspase‐3 Following Experimental Traumatic Brain Injury , 2000, Journal of neurochemistry.
[44] J. Pickard,et al. Jugular venous and arterial concentrations of serum S-100B protein in patients with severe head injury: a pilot study , 1998, Journal of neurology, neurosurgery, and psychiatry.
[45] R. Hayes,et al. Biomarkers of Proteolytic Damage Following Traumatic Brain Injury , 2004, Brain pathology.
[46] C. Lee,et al. Mitochondrial dysfunction and calcium perturbation induced by traumatic brain injury. , 1997, Journal of neurotrauma.
[47] H. Joller,et al. S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury. , 2001, Journal of neurotrauma.
[48] Henry L. Lew,et al. Rehabilitation needs of an increasing population of patients: Traumatic brain injury, polytrauma, and blast-related injuries. , 2005, Journal of rehabilitation research and development.
[49] F. Michetti,et al. S100B protein in biological fluids: a tool for perinatal medicine. , 2002, Clinical chemistry.
[50] S. Budd,et al. Mitochondria and neuronal survival. , 2000, Physiological reviews.
[51] D. Hovda,et al. Mitochondrial damage and dysfunction in traumatic brain injury. , 2004, Mitochondrion.
[52] A. Brawanski,et al. Early S-100B serum level correlates to quality of life in patients after severe head injury , 2002, Brain injury.
[53] S. Hanash,et al. Proteomics Approaches to Uncover the Repertoire of Circulating Biomarkers for Breast Cancer , 2002, Journal of Mammary Gland Biology and Neoplasia.
[54] H. Kitano,et al. Computational systems biology , 2002, Nature.
[55] P. Johnsson. Markers of cerebral ischemia after cardiac surgery. , 1996, Journal of cardiothoracic and vascular anesthesia.
[56] A. Marini,et al. Genomics and variation of ionotropic glutamate receptors: implications for neuroplasticity , 2005, Amino Acids.
[57] A. Brawanski,et al. Comparison of serial S-100 and NSE serum measurements after severe head injury , 2005, Acta Neurochirurgica.
[58] G. Fiskum,et al. Mitochondrial dysfunction early after traumatic brain injury in immature rats , 2007, Journal of neurochemistry.
[59] R. Vink,et al. Mitochondrial metabolism following traumatic brain injury in rats. , 1990, Journal of neurotrauma.
[60] T. Mathiesen,et al. Characterization of Bax and Bcl-2 in apoptosis after experimental traumatic brain injury in the rat , 2003, Acta Neuropathologica.
[61] M Aldea,et al. The nucleotide sequence of Saccharomyces cerevisiae chromosome XV. , 1997, Nature.
[62] Frank Vitzthum,et al. Proteomics: from basic research to diagnostic application. A review of requirements & needs. , 2005, Journal of proteome research.
[63] T. Beems,et al. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury , 2004, Neurology.
[64] S. Scheff,et al. Cyclosporin A significantly ameliorates cortical damage following experimental traumatic brain injury in rodents. , 1999, Journal of neurotrauma.
[65] E. Davidov,et al. Advancing drug discovery through systems biology. , 2003, Drug discovery today.
[66] B. Pike,et al. Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats. , 2001, Journal of neurochemistry.
[67] H. Kitano. Systems Biology: A Brief Overview , 2002, Science.
[68] R. Aebersold,et al. Mass spectrometry-based proteomics , 2003, Nature.
[69] W Ansorge,et al. The nucleotide sequence of Saccharomyces cerevisiae chromosome XII. , 1997, Nature.
[70] Jeremy J. Flint,et al. Accumulation of non‐erythroid αII‐spectrin and calpain‐cleaved αII‐spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats , 2001 .
[71] Adriana B Ferreira,et al. The Generation of a 17 kDa Neurotoxic Fragment: An Alternative Mechanism by which Tau Mediates β-Amyloid-Induced Neurodegeneration , 2005, The Journal of Neuroscience.
[72] J. Langlois,et al. The Incidence of Traumatic Brain Injury Among Children in the United States: Differences by Race , 2005, The Journal of head trauma rehabilitation.
[73] Kevin K W Wang,et al. Evidence for Activation of Caspase‐3‐Like Protease in Excitotoxin‐ and Hypoxia/Hypoglycemia‐Injured Neurons , 1998, Journal of neurochemistry.
[74] Robert W. Williams,et al. Informatics center for mouse genomics , 2007, Neuroinformatics.
[75] M. Mattson,et al. Traumatic brain injury alters synaptic homeostasis: implications for impaired mitochondrial and transport function. , 1998, Journal of neurotrauma.
[76] W. Mauritz,et al. Serum S 100 B: A Marker of Brain Damage in Traumatic Brain Injury with and without Multiple Trauma , 2003, Shock.
[77] S. Scheff,et al. Cleaved-tau: a biomarker of neuronal damage after traumatic brain injury. , 2005, Journal of neurotrauma.
[78] A. Raabe,et al. Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma. , 2004, The Journal of trauma.
[79] S. Grant,et al. Proteomics in postgenomic neuroscience: the end of the beginning , 2004, Nature Neuroscience.
[80] B. Pike,et al. Stretch injury causes calpain and caspase-3 activation and necrotic and apoptotic cell death in septo-hippocampal cell cultures. , 2000, Journal of neurotrauma.
[81] Kathryn Saatman,et al. Application of proteomics technology to the field of neurotrauma. , 2003, Journal of neurotrauma.
[82] J. García,et al. Functional and quantitative proteomics using SILAC in cancer research , 2008 .
[83] Bernard Dujon,et al. The nucleotide sequence of Saccharomyces , 1997 .
[84] C. Alling,et al. Elimination of S100B and renal function after cardiac surgery. , 2000, Journal of cardiothoracic and vascular anesthesia.
[85] P. Kochanek,et al. Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children. , 2005, Journal of neurosurgery.
[86] F. Tortella,et al. Novel Differential Neuroproteomics Analysis of Traumatic Brain Injury in Rats* , 2006, Molecular & Cellular Proteomics.
[87] TBI State Demonstration Grants , 1998, The Journal of head trauma rehabilitation.
[88] K. Blennow,et al. Proteome studies of human cerebrospinal fluid and brain tissue using a preparative two‐dimensional electophoresis approach prior to mass spectrometry , 2001, Proteomics.
[89] R. Anderson,et al. High serum S100B levels for trauma patients without head injuries. , 2001, Neurosurgery.
[90] R. Hayes,et al. Identification and preliminary validation of novel biomarkers of acute hepatic ischaemia/reperfusion injury using dual-platform proteomic/degradomic approaches , 2006, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[91] B. Romner,et al. Serial S-100 protein serum measurements related to early magnetic resonance imaging after minor head injury. Case report. , 1996, Journal of neurosurgery.
[92] S. Itohara,et al. Glial protein S100B modulates long-term neuronal synaptic plasticity , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[93] B. Romner,et al. The clinical value of serum S-100 protein measurements in minor head injury: a Scandinavian multicentre study. , 2000, Brain injury.
[94] F. Lecky,et al. Rapid elimination of protein S-100B from serum after minor head trauma. , 2006, Journal of neurotrauma.
[95] R. Raghupathi,et al. Cell Death Mechanisms Following Traumatic Brain Injury , 2004, Brain pathology.
[96] V. Seifert,et al. Serum S-100B protein as a molecular marker in severe traumatic brain injury. , 2003, Restorative neurology and neuroscience.
[97] R. Neumar,et al. Proteins released from degenerating neurons are surrogate markers for acute brain damage , 2004, Neurobiology of Disease.
[98] D. Choi,et al. Bench to bedside: the glutamate connection. , 1992, Science.
[99] R. Wells,et al. Serum neuron-specific enolase as a predictor of short-term outcome in children with closed traumatic brain injury. , 2005, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[100] R. Schmidhammer,et al. Circulating S100B is increased after bilateral femur fracture without brain injury in the rat. , 2003, British journal of anaesthesia.
[101] D. Choi. Excitotoxic cell death. , 1992, Journal of neurobiology.
[102] B. Romner,et al. High Serum S100B Levels for Trauma Patients without Head Injuries. , 2001, Neurosurgery.
[103] B. Pike,et al. Regional calpain and caspase‐3 proteolysis of α‐spectrin after traumatic brain injury , 1998, Neuroreport.
[104] M. Plotkine,et al. Characterization of a rat model to study acute neuroinflammation on histopathological, biochemical and functional outcomes , 2005, Journal of Neuroscience Methods.
[105] Alexander Sasha Rabchevsky,et al. Mitochondrial permeability transition in CNS trauma: Cause or effect of neuronal cell death? , 2005, Journal of neuroscience research.
[106] A. Raabe,et al. GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome. , 2004, Journal of neurotrauma.
[107] W Ansorge,et al. The nucleotide sequence of Saccharomyces cerevisiae chromosome XVI. , 1997, Nature.
[108] H. Joller,et al. S-100β reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury , 2001 .
[109] David Botstein,et al. The nucleotide sequence of yeast chromosome XVI , 1997 .
[110] E. Hall,et al. Attenuation of acute mitochondrial dysfunction after traumatic brain injury in mice by NIM811, a non-immunosuppressive cyclosporin A analog , 2008, Experimental Neurology.
[111] V. Seifert,et al. Serum markers of brain damage and outcome prediction in patients after severe head injury. , 1999, British journal of neurosurgery.
[112] M. Wunderlich,et al. Release of glial fibrillary acidic protein is related to the neurovascular status in acute ischemic stroke , 2006, European journal of neurology.
[113] S. Margulies,et al. Traumatic axonal injury is exacerbated following repetitive closed head injury in the neonatal pig. , 2004, Journal of neurotrauma.
[114] Marcus Svensson,et al. A neuroproteomic approach to targeting neuropeptides in the brain , 2002, Proteomics.
[115] H. Xiong,et al. [Pathophysiological alterations in cultured astrocytes exposed to hypoxia/reoxygenation]. , 2000, Sheng li ke xue jin zhan [Progress in physiology].
[116] T. Wieloch,et al. Mitochondrial permeability transition in acute neurodegeneration. , 2002, Biochimie.
[117] V. Seifert,et al. Fatal secondary increase in serum S-100B protein after severe head injury. Report of three cases. , 1999, Journal of neurosurgery.
[118] W. Geraerts,et al. Protein synthesis in synaptosomes: a proteomics analysis , 2002, Journal of neurochemistry.
[119] B. Dujon,et al. The nucleotide sequence of Saccharomyces cerevisiae chromosome VII. , 1997, Nature.
[120] Steven A Carr,et al. Protein biomarker discovery and validation: the long and uncertain path to clinical utility , 2006, Nature Biotechnology.
[121] C. Vorhees,et al. Methamphetamine enhances the cleavage of the cytoskeletal protein tau in the rat brain , 2003, Neuroscience.
[122] Eric Boerwinkle,et al. Gene expression profiling and functional proteomic analysis reveal perturbed kinase-mediated signaling in genetic stroke susceptibility. , 2003, Physiological genomics.
[123] J. James. Unproven diagnostic and therapeutic techniques , 2002, Current Allergy and Asthma Reports.
[124] D. Goldman,et al. Genomics and Variation of Ionotropic Glutamate Receptors , 2003, Annals of the New York Academy of Sciences.
[125] D. Prough,et al. Analysis of long-term gene expression in neurons of the hippocampal subfields following traumatic brain injury in rats , 2005, Neuroscience.
[126] D. Thompson,et al. Application of proteomic technologies in the drug development process. , 2003, Toxicology letters.
[127] F. Tortella,et al. Accumulation of Calpain and Caspase-3 Proteolytic Fragments of Brain-Derived αII-Spectrin in Cerebral Spinal Fluid after Middle Cerebral Artery Occlusion in Rats , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[128] A. Raabe. High serum S100B levels for trauma patients without head injuries. , 2001, Neurosurgery.
[129] R. Hayes,et al. Rapid discovery of putative protein biomarkers of traumatic brain injury by SDS-PAGE-capillary liquid chromatography-tandem mass spectrometry. , 2005, Journal of neurotrauma.
[130] D. Desiderio,et al. Analysis of the human lumbar cerebrospinal fluid proteome , 2002, Electrophoresis.
[131] K. Johnson,et al. Chronic phencyclidine increases NMDA receptor NR1 subunit mRNA in rat forebrain , 1999, Journal of neuroscience research.
[132] A. Can,et al. Attenuation of microtubule associated protein-2 degradation after mild head injury by mexiletine and calpain-2 inhibitor , 2007, British journal of neurosurgery.
[133] D. Wallace. Mitochondrial diseases in man and mouse. , 1999, Science.
[134] K. Sandelin,et al. Proteomic Characterization of the Interstitial Fluid Perfusing the Breast Tumor Microenvironment , 2004, Molecular & Cellular Proteomics.
[135] R. Neumar,et al. Comparison of Calpain and Caspase Activities in the Adult Rat Brain after Transient Forebrain Ischemia , 2002, Neurobiology of Disease.
[136] T. Neumann-Haefelin,et al. Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[137] R. Ergün,et al. Prognostic value of serum neuron-specific enolase levels after head injury. , 1998, Neurological research.
[138] I. Zagon,et al. Brain spectrin(240/235) and brain spectrin(240/235E): two distinct spectrin subtypes with different locations within mammalian neural cells , 1986, The Journal of cell biology.
[139] J. Yates,et al. Shotgun Proteomics and Biomarker Discovery , 2002, Disease markers.
[140] 山崎 義矩. Diagnostic significance of serum neuron-specific enolase and myelin basic protein assay in patients with acute head injury , 1994 .
[141] R. Hayes,et al. Concurrent calpain and caspase-3 mediated proteolysis of alpha II-spectrin and tau in rat brain after methamphetamine exposure: a similar profile to traumatic brain injury. , 2005, Life sciences.
[142] Firas Kobeissy,et al. Proteomics studies of traumatic brain injury. , 2004, International review of neurobiology.
[143] J. Rossier,et al. Identification of brain cell death associated proteins in human post-mortem cerebrospinal fluid. , 2006, Journal of proteome research.
[144] T. Emanuelli,et al. Neurochemical characterization of traumatic brain injury in humans. , 2001, Journal of neurotrauma.
[145] C. Alling,et al. Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulation. , 2000, The Annals of thoracic surgery.
[146] T. Boyer,et al. Identification of a short form of ubiquitin-specific protease 3 that is a repressor of rat glutathione S-transferase gene expression. , 2006, The Biochemical journal.
[147] Vidya N. Nukala,et al. Proteomic identification of oxidized mitochondrial proteins following experimental traumatic brain injury. , 2007, Journal of neurotrauma.
[148] T. Ideker,et al. Network genomics. , 2007, Ernst Schering Research Foundation workshop.
[149] P. Urdal,et al. Increased serum creatine kinase BB and neuron specific enolase following head injury indicates brain damage , 2005, Acta Neurochirurgica.
[150] L. Liotta,et al. CSF proteome: a protein repository for potential biomarker identification , 2005, Expert review of proteomics.
[151] A. Brawanski,et al. S-100 serum levels after minor and major head injury. , 1998, The Journal of trauma.
[152] Jean-Paul Noben,et al. Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients , 2004, Proteomics.
[153] Roger E Bumgarner,et al. Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. , 2001, Science.
[154] S. Orencole,et al. Array-based ELISAs for high-throughput analysis of human cytokines. , 2001, BioTechniques.
[155] W. Hermens,et al. Fatty acid-binding proteins as plasma markers of tissue injury. , 2005, Clinica chimica acta; international journal of clinical chemistry.
[156] A. Sikorski,et al. Spectrin and calpain: a ‘target’ and a ‘sniper’ in the pathology of neuronal cells , 2005, Cellular and Molecular Life Sciences CMLS.
[157] Manfred Herrmann,et al. Release of Glial Tissue–Specific Proteins After Acute Stroke: A Comparative Analysis of Serum Concentrations of Protein S-100B and Glial Fibrillary Acidic Protein , 2000, Stroke.
[158] S. Grant,et al. Systems biology in neuroscience: bridging genes to cognition , 2003, Current Opinion in Neurobiology.
[159] S. Hunsucker,et al. Proteomic analysis of multiple sclerosis cerebrospinal fluid , 2004, Multiple sclerosis.
[160] I. Zagon,et al. Brain spectrin: Of mice and men , 1995, Brain Research Bulletin.
[161] T. Ideker,et al. A new approach to decoding life: systems biology. , 2001, Annual review of genomics and human genetics.
[162] R. Donato,et al. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. , 1999, Biochimica et biophysica acta.
[163] Takashi Yamauchi,et al. Molecular constituents of the postsynaptic density fraction revealed by proteomic analysis using multidimensional liquid chromatography‐tandem mass spectrometry , 2003, Journal of neurochemistry.
[164] A. Brawanski,et al. Comparison of clinical, radiologic, and serum marker as prognostic factors after severe head injury. , 1999, The Journal of trauma.
[165] A. Twijnstra,et al. S‐100B and neuron‐specific enolase in serum of mild traumatic brain injury patients A comparison with healthy controls , 2001, Acta neurologica Scandinavica.
[166] Jing Zhang,et al. Identification of proteins involved in microglial endocytosis of alpha-synuclein. , 2007, Journal of proteome research.
[167] C. Price,et al. The Early Fall in Levels of S-100 β in Traumatic Brain Injury , 2000 .
[168] L. Lv,et al. High-throughput antibody microarrays for quantitative proteomic analysis , 2007, Expert review of proteomics.